Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis
Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). ... Read more
-
-
Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests
Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when ... Read more -
EMA Accepts Humira and Remicade Biosimilars for Regulatory Review
The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for ... Read more -
DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds
Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), Remicade ... Read more -
Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs
Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of ... Read more
Phase 3 Trial Finds Kevzara Superior to Humira, and Just as Safe, in Treating Rheumatoid Arthritis
News, rheumatoid arthritis
The drug Kevzara (sarilumab) is more effective than Humira (adalimumab) — and just as safe — in treating rheumatoid arthritis (RA) ... Read more
Despite Treatment, 80% of RA Patients Report ‘Life-Altering’ Pain Weekly or Even Daily, Survey Finds
News
Honestly RA, an online survey for Americans with rheumatoid arthritis (RA), found that although most RA patients agree that the treatments improve their ... Read more
Kevzara Takes Step Toward EU Approval, While FDA Decision Is Expected in May
News, rheumatoid arthritis
Kevzara (sarilumab) has received a thumbs-up from the European Medicine Agency (EMA), which has recommended that the European Commission approve it ... Read more
Rheumatoid Arthritis Patients More Likely to Develop Atherosclerosis, British Study Shows
News, rheumatoid arthritis
People with rheumatoid arthritis (RA) are more likely to develop atherosclerosis, a chronic inflammatory condition affecting the heart, according to new research. ... Read more
Phase 3 Trial of Can-Fite’s Piclidenoson for Treating RA Is Underway
News
Can-Fite BioPharma’s Phase 3 ACRobat clinical trial protocol was approved by Barzilai Medical Center’s Institutional Review Board (IRB) and patient enrollment ... Read more
Researchers Find 2 Potential Molecules for Fighting Rheumatoid Arthritis, Other Inflammatory Diseases
News, rheumatoid arthritis
Greek researchers have found two molecules — T23 and T8 — that show promise in treating rheumatoid arthritis and other chronic ... Read more
Early Treatment Improves Rheumatoid Arthritis Symptoms, Helps Patients Live Longer, Study Suggests
News, rheumatoid arthritis
Earlier and more aggressive treatment of rheumatoid arthritis (RA) helps patients grip things, walk and dress themselves better — and live ... Read more
Inmedix, Omegawave to Adapt Elite-athlete Tests to Rheumatoid Arthritis Diagnosis
News, rheumatoid arthritis
Inmedix and Omegawave will work together on medical applications of tests related to athletes’ performance, with one target being rheumatoid arthritis (RA). ... Read more
FDA Asks More Information a Second Time on Baricitinib as Arthritis Therapy
News, rheumatoid arthritis
U.S. regulators want additional dosing- and safety-related information before they will approve Eli Lilly and Incyte‘s New Drug Application (NDA) request for ... Read more
Obesity May Alter Diagnosis, Management of RA When Blood Tests Are Used
News, rheumatoid arthritis
Obesity in women may interfere with the diagnosis and monitoring of rheumatoid arthritis (RA) through blood tests, according to a new ... Read more